- Zoetis announced its fourth-quarter dividend. The dividend will be paid by the company on December 1, 2023.
- CEO of Zoetis Plc is Kristin Peck. The company was established 71 years ago in 1952.
The largest manufacturer of medication and immunizations for pets and animals worldwide is an American pharmaceutical business called Zoetis Inc. The business was a division of Pfizer, the biggest pharmaceutical firm in the world. The business distributes its goods in over 100 countries and directly markets them in about 45 of those nations.
Technical Analysis of the ZTS Stock

Since November 2022, the Zoetis Stock has performed nicely in the 1-D analysis. It is going in an upward direction. The strength of the line is enhanced by the abundance of support points. It has decreased by 0.57% today. Overall, there has been a 430% improvement.
On December 30, 2021, the stock reached its highest point, which was approximately $248.
The falling three patterns imply that the stock will show negative signs in the future. The stock in the last 6 months is down by 4.93% and last month it was down by 8.80%. In the Last 5 years, the ZTS stock has been up by 82.17%. It was up by 13.27% in the last year. In the 5-D analysis, the stock was up by 4.53%.
Zoetis Plc: Financial Statements Analysis
On February 14, 2023, the company released its annual report. According to the reports, the firm’s overall revenue for 2022 was $8.08 billion. The company’s gross profit in 2022 was $5.48 billion.
In 2022, the business faced an operating profit of $2.93 billion. In 2022, its net income was $2.11 billion. The company’s financial statements were performing strong in the year 2022.
Technical Index
The RSI line is below the 50 level it is around 39.05 which means the stock losses are more than the gains in the price. The EMA-100 days indicate selling action at the $176.90 price level. It’s 200 days- EMA implies selling at the $174.14 price level.
The 100 Days- SMA provides selling at a $177.31 market price. Its SMA- 200 Days shows selling action at $173.07.
Live Chart of ZTS
Conclusion
In a few weeks, the price of the Zoetis Stock may increase by 2.24%. It suggests that costs may be close to $171.80. The recent 30-day period saw a 2.67% increase in the price volatility of the current market. Experts and research predict that its tendency will continue to gain strength. If it carries the same momentum.
Technical Levels
- Support level- $160.84 and $143.66
- Resistance level- $202.62 and $196.73
Disclaimer
The views and opinions stated by the author, or any people named in this article, are for informational purposes only and do not establish financial, investment, or other advice. Investing in or trading crypto or stock comes with a risk of financial loss.




